Jul 9, 2024 | 2024, Events, Investors
Management will provide an update on the industrial programs, including on the topline results from the Nidlegy™ Phase III trial presented at ASCO 2024. Please contact us at IR@philogen.com or follow the link register to the event.
May 27, 2024 | 2024, Investors, Press Releases
more details
May 24, 2024 | 2024, Events, Investors
The conference provides an opportunity for investors to learn about Philogen’s progress and to meet CEO/CSO Prof. Dario Neri through a series of one-on-one meetings. Prof. Neri will give a presentation on June 12 at 1:20 pm. Follow the link here for more...
Recent Comments